VolitionRx Ltd.

In News

VolitionRX Ltd (VNRX) Q3 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance

Yahoo Finance - Nov 13, 2025

Simple blood tests for cancer and sepsis move closer to hospitals in 2025 - Stock Titan

Stock Titan - Dec 17, 2025

Earnings call transcript: VolitionRx Ltd reports Q3 2025 revenue growth, stock stable - Investing.com

Investing.com - Nov 14, 2025

VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships - The Globe and Mail

The Globe and Mail - Nov 16, 2025

VolitionRx Limited Reports Q3 2025 Financial Growth - TipRanks

TipRanks - Nov 14, 2025

VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... - Yahoo Finance

Yahoo Finance - Nov 14, 2025

VolitionRx (NYSE AMERICAN: VNRX) named sole biomarker partner in €6.3M DETECSEPS sepsis detection program - Stock Titan

Stock Titan - Dec 04, 2025

Still buys VolitionRx (VNRX) shares and warrants for $24,518 - Investing.com

Investing.com - Oct 15, 2025

Nu.Q Cancer Assays Sold for Certification at Lyon Center, VolitionRx (NYSE: VNRX) - Stock Titan

Stock Titan - Nov 25, 2025

VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Yahoo Finance

Yahoo Finance - Nov 10, 2025

Reynolds, Volitionrx CEO, buys $7,000 in VNRX stock - Investing.com

Investing.com - Nov 17, 2025

VolitionRX Ltd (VNRX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones - Yahoo Finance

Yahoo Finance - May 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment